The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction

BACKGROUND: Previous ischemic stroke is a predictor of recurrent ischemic stroke after an acute myocardial infarction (AMI). Dual antiplatelet therapy, including a P2Y12-inhibitor, is important in secondary prevention after AMI. Ticagrelor, a P2Y12-inhibitor, is more potent than the commonly used cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksson, Robin, Björklund, Fredrik, Mooe, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502343/
https://www.ncbi.nlm.nih.gov/pubmed/31059535
http://dx.doi.org/10.1371/journal.pone.0216404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502343/
https://www.ncbi.nlm.nih.gov/pubmed/31059535
http://dx.doi.org/10.1371/journal.pone.0216404

Ejemplares similares